Floatz logo

Anti Cd30 Car-T Cell

Mediastinal B-Cell Diffuse Large Cell Lymphoma

Zhejiang UniversityCell therapyEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

86 Active assets in the Mediastinal B-Cell Diffuse Large Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Ifosfamide
David Bond, MD
Phase 4BBB
Inno-206
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 4BBB
ETOPOSIDE
University of Washington
Phase 4BBB
ETOPOSIDE
University of Washington
Phase 4BBB
Inno-206
University of Washington
Phase 4BBB

View all 50 →

Same molecule, other indications

Anti Cd30 Car-T Cell is also rated in:

extranodal nasal NK/T cell lymphomaDormant
C
Indicative ·
39 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedDormant
C
Indicative ·
39 / 100
View asset →
B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphomaDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →